Naamit Sher, Ph.d
Vice President, Development and Regulatory
drug development
Vascular Biogenics
Israel
Biography
Dr. Sher Joined VBL in 2006. She was previously Head of QC Laboratories, Operations Division at Teva, and QC/QA Director at InterPharm, Subsidiary of Ares-Serono gaining 15 years of drug development and regulatory experience. Dr. Sher holds a Ph.D. from the Hebrew University, Israel and completed a post-doctoral fellowships at the Hebrew University, Jerusalem and at Rutgers University, New Jersey, U.S.
Research Interest
drug development
